LEIPZIG, GERMANY—Two new analyses presented here support the use of endovascular drug-coated balloon (DCB) therapy in a variety of complex patient subsets, including long femoropopliteal lesions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback